Literature DB >> 31277039

Novel bioresorbable tricalcium phosphate/polyhydroxyoctanoate (TCP/PHO) composites as scaffolds for bone tissue engineering applications.

Ewelina Cichoń1, Katarzyna Haraźna2, Szymon Skibiński1, Tomasz Witko3, Aneta Zima1, Anna Ślósarczyk1, Małgorzata Zimowska2, Małgorzata Witko2, Bartosz Leszczyński3, Andrzej Wróbel3, Maciej Guzik4.   

Abstract

Development of new composite materials for bone tissue engineering is a constantly growing field of medicine. Therefore there is a continuous need in creating novel materials that can not only regenerate the defected tissue but also nourish it while the healing process progresses. Here we present a novel type of composite material that fulfils these requirements. The study describes creation of a composite with macroporous bioceramic core that is infiltrated with a thin biopolymer layer. The ceramic component, namely tricalcium phosphate (TCP), due to its mechanistic and bioactive properties may promote new bone creation as shown through the in vitro studies. To the best of our knowledge the coating layer was created for the first time from a representative of bacterially derived medium chain length polyhydroxyalkanoate polymers (mcl-PHA), namely polyhydroxyoctanoate (PHO). This polymer layer not only profoundly changed the stress-strain characteristics of the bioceramic foam but also released (R)-3-hydroxyacids and their dimers/trimers to the investigated environment. In the manuscript we have in depth characterised these materials employing a set of basic procedures, through 3D structure reconstruction and finishing with prolonged in vitro experiments.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Year:  2019        PMID: 31277039     DOI: 10.1016/j.jmbbm.2019.06.028

Source DB:  PubMed          Journal:  J Mech Behav Biomed Mater        ISSN: 1878-0180


  7 in total

Review 1.  Review of the Developments of Bacterial Medium-Chain-Length Polyhydroxyalkanoates (mcl-PHAs).

Authors:  V Uttej Nandan Reddy; S V Ramanaiah; M Venkateswar Reddy; Young-Cheol Chang
Journal:  Bioengineering (Basel)       Date:  2022-05-21

2.  Development of highly porous calcium phosphate bone cements applying nonionic surface active agents.

Authors:  Ewelina Cichoń; Bartosz Mielan; Elżbieta Pamuła; Anna Ślósarczyk; Aneta Zima
Journal:  RSC Adv       Date:  2021-07-06       Impact factor: 4.036

3.  Physicochemical and Biological Characterisation of Diclofenac Oligomeric Poly(3-hydroxyoctanoate) Hybrids as β-TCP Ceramics Modifiers for Bone Tissue Regeneration.

Authors:  Katarzyna Haraźna; Ewelina Cichoń; Szymon Skibiński; Tomasz Witko; Daria Solarz; Iwona Kwiecień; Elena Marcello; Małgorzata Zimowska; Robert Socha; Ewa Szefer; Aneta Zima; Ipsita Roy; Konstantinos N Raftopoulos; Krzysztof Pielichowski; Małgorzata Witko; Maciej Guzik
Journal:  Int J Mol Sci       Date:  2020-12-11       Impact factor: 5.923

Review 4.  Polyhydroxyalkanoates, bacterially synthesized polymers, as a source of chemical compounds for the synthesis of advanced materials and bioactive molecules.

Authors:  Maciej W Guzik
Journal:  Appl Microbiol Biotechnol       Date:  2021-09-18       Impact factor: 4.813

5.  Injectable demineralized bone matrix particles and their hydrogel bone grafts loaded with β-tricalcium phosphate powder and granules: A comparative study.

Authors:  Hoe-Jin Kang; Seong-Su Park; Garima Tripathi; Byong-Taek Lee
Journal:  Mater Today Bio       Date:  2022-09-09

6.  Study on βTCP/P(3HB) Scaffolds-Physicochemical Properties and Biological Performance in Low Oxygen Concentration.

Authors:  Szymon Skibiński; Joanna P Czechowska; Ewelina Cichoń; Martyna Seta; Agata Gondek; Agnieszka Cudnoch-Jędrzejewska; Anna Ślósarczyk; Maciej Guzik; Aneta Zima
Journal:  Int J Mol Sci       Date:  2022-09-30       Impact factor: 6.208

7.  Vimentin Association with Nuclear Grooves in Normal MEF 3T3 Cells.

Authors:  Karolina Feliksiak; Tomasz Witko; Daria Solarz; Maciej Guzik; Zenon Rajfur
Journal:  Int J Mol Sci       Date:  2020-10-10       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.